DRUG APPROVALS: FEBRUARY 2011
FEBRUARY 3: MAKENA (17-ALPHA HYDROXYPROGESTERONE CAPROATE) INJECTION
TREATMENT- PREMATURE LABOR
FEBRUARY 17: CORIFACT (FACTOR XIII CONCENTRATE HUMAN)
TREATMENT- FACTOR XIII DEFICIENCY
FEBRUARY 25: EDARBI (AZILSARTAN MEDOXOMIL) TABLETS
TREATMENT- HYPERTENSION
FEBRUARY 28: DALIRESP (ROFLUMAILAST) TABLETS
TREATMENT- CHRONIC OBSTRUCTIVE PULMONARY DISEASE
